Figure 4.
Spectrophotometric time-scans demonstrating the ability of fraction F18 (n-Octadecanyl-O-α-D-glucopyranosyl (6′ → 1″)-O-α-D-glucopyranoside) (a) and pravastatin (b) to inhibit HMG-CoA reductase activity.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.